Scaling effective research partnerships

Our approaches to research

COLLABORATION

• Deidentified data sharing
  • Clinical data
  • Operational data
• Multi-site study recruitment
• Patient identification for research interventions
• Care Plan Research to increase clinical trial Enrollments (Ft. iCARE Registry)
• Multi-Side Study Recruitment with sites across the country with diverse patient populations
• Library of deidentified clinical and operational data to develop solutions targeted towards improving uptake of high risk interventions

TECHNOLOGY

• Technology platform partner for conducting studies
• Use CancerIQ to identify patients at high-risk of: hereditary cancer, lung, colon, cervical, breast, and prostate cancer
• Develop interventions to improve uptake of appropriate preventive services, patient communication, patient education, AI Large Language models
• Research customization beyond our base product
  • Custom data collection
  • Custom risk models
  • Custom eligibility and followup

Implementation Models Study: Boston University & CancerIQ

Peer-reviewed research shows CancerIQ more than doubles genetic testing uptake

To identify more effective models for cancer genetic testing, a team of researchers from Boston University School of Public Health, CancerIQ, and University of Washington School of Public Health analyzed patient uptake of genetic counseling and testing after conducting digital cancer risk assessment with CancerIQ.

"Clinical workflows that combine point-of-care genetic testing with CancerIQ, the platform powering early cancer detection and prevention across broad patient populations, more than double the average uptake of genetic testing for hereditary cancer syndromes."

— Healthcare Innovation

READ THE STUDY

CancerIQ Research Experience

MAY 2023

Adventist Health

Patient Uptake of Genetic Testing: A Cross-Sectional Analysis of Clinical Settings and Provider Types

JANUARY 2023

Adventist Health

Cancer Risk Assessment and Genetic Testing Uptake in a Real-World Breast Imaging Setting

APRIL 2022

Boston University

Predictors of genetic testing uptake following the implementation of a digital system to facilitate population-based risk assessment for hereditary cancer syndromes

FEBRUARY 2022

Boston University

Challenges in efforts to increase access to hereditary cancer genetic counseling and testing for underrepresented populations

AUGUST 2022

Adventist Health

CancerIQ’s FHIR-based App Drives Exponential Increase in Genomic Testing

APRIL 2021

Adventist Health / OSF

Adventist Health, OSF HealthCare Use CancerIQ to Prioritize Patients for Preventive Cancer Screenings

FEBRUARY 2021

Dignity Healthcare

CancerIQ, Dignity Health and Advisory Board conducted two virtual sessions at the Association of Community Cancer Centers (ACCC) 47th Annual Meeting & Cancer Center Business Summit

MAY 2020

Dignity Healthcare

How Dignity Health keeps patients connected to telegenetics—during and beyond Covid-19

APRIL 2020

University of Washington

Communication is Key: The Impact of Mammotech Communication on Patient Uptake of High-Risk Programs

JUNE 2019

St. Genevieve Medical Ctr

Impact of Hereditary Cancer Screening in Diverse Practice Settings on Gastroenterology Volume

MARCH 2019

Riverside Healthcare

From Paper to Tablet: Improving Effectiveness in Identifying High Risk Women in the Mammography Setting

MARCH 2019

OSF Healthcare

How OSF Healthcare implemented its high-risk screening and genetic counseling program into its community setting

FEBRUARY 2019

Sharp Healthcare

How Sharp HealthCare is improving access to genetic counseling

JANUARY 2019

OSF Healthcare

Using Technology to Expand Genetic Testing: Recognizing and Empowering Those at High Risk in Community Settings.

OCTOBER 2018

OSF Healthcare

Innovative Technology to Improve Navigation for Genetic Cancer Risk Assessment Services

SEPTEMBER 2018

ProHEALTH

Increased Yield of Hereditary Cancer Risk Assessment in GI Practice Using NCCN Guidelines and Panel Testing

MARCH 2018

OSF Healthcare

Innovative Technology to Improve Navigation for Genetic Cancer Risk Assessment Services